Biogen’s Henshaw Insists Data Is Key In Bolstering Biosimilars

Data published by Biogen is a key factor in driving uptake and acceptance of its biosimilars, the firm’s head of biosimilars, Ian Henshaw, told Generics Bulletin in an exclusive interview.